Department of Social and Behavioral Sciences, Indiana University Richard M. Fairbanks School of Public Health, Indianapolis, IN (SG), RAND Corporation, CA (SG, ERP, SBH, DK), RAND Corporation, Arlington, VA (BAG).
J Addict Med. 2020 Jul/Aug;14(4):e83-e88. doi: 10.1097/ADM.0000000000000605.
Key stakeholders can have differing views about which information is essential to inform placement decisions for all patients. This study examined consensus across stakeholder groups on the most important individual needs and treatment outcomes for informing decisions specifically about the level of care for an adolescent in substance use treatment.
We conducted an online modified-Delphi process with treatment providers, policymakers, researchers, and parents of adolescents who have received substance use treatment. Participants rated 48 individual needs from the Global Appraisal of Individual Needs-Initial that were mapped onto the 6 dimensions of the American Society of Addiction Medicine Criteria. In addition, participants rated 10 treatment outcomes from the Substance Abuse and Mental Health Services Administration's National Outcome Measures. We assessed consensus within stakeholder groups using the RAND/UCLA Appropriateness Method. We considered the items reaching consensus with the highest ratings across stakeholder groups as the most important individual needs and treatment outcomes.
We recruited 194 participants (81 providers, 54 policymakers, 32 researchers, 27 parents). Participants identified suicidality and severity of substance use disorder symptoms as the most important individual needs, and reduction in substance use as the most important treatment outcome.
Standardized procedures for matching adolescents to levels of care for substance use treatment should at a minimum be based on assessments of suicidality and severity of substance use disorder symptoms, and consider reduction in substance use as a primary treatment outcome. These findings can progress the development of "level-of-care" decision rules specifically for adolescents.
关键利益相关者对于哪些信息对于告知所有患者的安置决策至关重要可能存在不同的看法。本研究考察了利益相关者群体在特定于青少年物质使用治疗护理水平的决策中,告知决策的最重要的个体需求和治疗结果方面的共识。
我们使用治疗提供者、政策制定者、研究人员和接受过物质使用治疗的青少年的父母进行了在线修改后的 Delphi 过程。参与者对映射到美国成瘾医学协会标准 6 个维度的全球个体需求初始评估中的 48 个个体需求进行了评分。此外,参与者还对物质滥用和心理健康服务管理局的国家结果衡量标准中的 10 个治疗结果进行了评分。我们使用 RAND/UCLA 适宜性方法评估了利益相关者群体内的共识。我们认为在所有利益相关者群体中获得最高评分的项目是最重要的个体需求和治疗结果。
我们招募了 194 名参与者(81 名提供者、54 名政策制定者、32 名研究人员、27 名父母)。参与者将自杀意念和物质使用障碍症状的严重程度确定为最重要的个体需求,将物质使用减少确定为最重要的治疗结果。
用于匹配青少年接受物质使用治疗的护理水平的标准化程序至少应基于自杀意念和物质使用障碍症状的严重程度评估,并且应将物质使用减少作为主要治疗结果考虑。这些发现可以促进为青少年专门制定“护理水平”决策规则的发展。